Jasper Therapeutics (JSPRW) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.01

DCF Value+14364.91%

$1.16

Potential upside vs current price

Current Stock Price

$0.01

DCF Value+14364.91%

$1.16

Potential upside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.01

DCF Value+14364.91%

$1.16

Potential upside vs current price

Current Stock Price

$0.01

DCF Value+14364.91%

$1.16

Potential upside vs current price

Jasper Therapeutics, Inc.